Literature DB >> 16820147

Functional expression of the P2Y14 receptor in human neutrophils.

Michelle Scrivens1, John M Dickenson.   

Abstract

Previous studies using quantitative reverse transcriptase polymerase chain reaction (RT-PCR) analysis have shown that the P2Y(14) receptor is expressed at high levels in human neutrophils. Therefore the primary aim of this study was to determine whether the P2Y(14) receptor is functionally expressed in human neutrophils. In agreement with previous studies RT-PCR analysis detected the expression of P2Y(14) receptor mRNA in human neutrophils. UDP-glucose (IC(50)=1 microM) induced a small but significant inhibition (circa 30%) of forskolin-stimulated cAMP accumulation suggesting functional coupling of endogenously expressed P2Y(14) receptors to the inhibition of adenylyl cyclase activity in human neutrophils. In contrast, the other putative P2Y(14) receptor agonists UDP-galactose and UDP-glucuronic acid (at concentrations up to 100 microM) had no significant effect, whereas 100 microM UDP-N-acetylglucosamine-induced a small but significant inhibition of forskolin-stimulated cAMP accumulation (20% inhibition). UDP-galactose, UDP-glucuronic acid and UDP-N-acetylglucosamine behaved as partial agonists by blocking UDP-glucose mediated inhibition of forskolin-induced cAMP accumulation. Treatment of neutrophils with pertussis toxin (G(i/o) blocker) abolished the inhibitory effects of UDP-glucose on forskolin-stimulated cAMP accumulation. UDP-glucose (100 microM) also induced a modest increase in extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation, whereas the other sugar nucleotides had no effect on ERK1/2 activation. Finally, UDP-glucose and related sugar nucleotides had no significant effect on N-formyl-methionyl-leucyl-phenylalanine-induced elastase release from neutrophils. In summary, although we have shown that the P2Y(14) receptor is functionally expressed in human neutrophils (coupling to inhibition of forskolin-induced cAMP and ERK1/2 activation) it does not modulate neutrophil degranulation (assessed by monitoring elastase release). Clearly further studies are required in order to establish the functional role of the P2Y(14) receptor expressed in human neutrophils.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16820147     DOI: 10.1016/j.ejphar.2006.05.037

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  40 in total

Review 1.  Signalling and pharmacological properties of the P2Y receptor.

Authors:  T K Harden; J I Sesma; I P Fricks; E R Lazarowski
Journal:  Acta Physiol (Oxf)       Date:  2010-03-24       Impact factor: 6.311

2.  GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity.

Authors:  Jianfeng Xu; Hidetaka Morinaga; Dayoung Oh; Pingping Li; Ai Chen; Saswata Talukdar; Yaël Mamane; Joseph A Mancini; Andrea R Nawrocki; Eduardo Lazarowski; Jerrold M Olefsky; Jane J Kim
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

3.  Structure-activity relationship of uridine 5'-diphosphoglucose analogues as agonists of the human P2Y14 receptor.

Authors:  Hyojin Ko; Ingrid Fricks; Andrei A Ivanov; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2007-04-04       Impact factor: 7.446

4.  Coordinated release of nucleotides and mucin from human airway epithelial Calu-3 cells.

Authors:  Silvia M Kreda; Seiko F Okada; Catharina A van Heusden; Wanda O'Neal; Sherif Gabriel; Lubna Abdullah; C William Davis; Richard C Boucher; Eduardo R Lazarowski
Journal:  J Physiol       Date:  2007-07-26       Impact factor: 5.182

5.  Similarities between UDP-glucose and adenine nucleotide release in yeast: involvement of the secretory pathway.

Authors:  Charles R Esther; Juliana I Sesma; Henrik G Dohlman; Addison D Ault; Marién L Clas; Eduardo R Lazarowski; Richard C Boucher
Journal:  Biochemistry       Date:  2008-08-12       Impact factor: 3.162

6.  The inflammatory effects of UDP-glucose in N9 microglia are not mediated by P2Y14 receptor activation.

Authors:  Vielska M Brautigam; George R Dubyak; Jessica M Crain; Jyoti J Watters
Journal:  Purinergic Signal       Date:  2008-02-08       Impact factor: 3.765

7.  Regulation of innate immunity by extracellular nucleotides.

Authors:  Stefania Gorini; Lucia Gatta; Laura Pontecorvo; Laura Vitiello; Andrea la Sala
Journal:  Am J Blood Res       Date:  2013-01-17

Review 8.  Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.

Authors:  Fenila Jacob; Claudina Pérez Novo; Claus Bachert; Koen Van Crombruggen
Journal:  Purinergic Signal       Date:  2013-02-13       Impact factor: 3.765

9.  Selective induction of P2Y14 receptor by RANKL promotes osteoclast formation.

Authors:  Seung Ah Lee; Jin Hee Park; Soo Young Lee
Journal:  Mol Cells       Date:  2013-09-17       Impact factor: 5.034

10.  The G protein-coupled receptor P2Y14 influences insulin release and smooth muscle function in mice.

Authors:  Jaroslawna Meister; Diana Le Duc; Albert Ricken; Ralph Burkhardt; Joachim Thiery; Helga Pfannkuche; Tobias Polte; Johannes Grosse; Torsten Schöneberg; Angela Schulz
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.